Citigroup’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $462K | Buy |
4,884
+3,217
| +193% | +$304K | ﹤0.01% | 2974 |
|
|
2025
Q1 | $106K | Buy |
1,667
+201
| +14% | +$12.8K | ﹤0.01% | 3807 |
|
|
2024
Q4 | $68.1K | Buy |
1,466
+185
| +14% | +$8.59K | ﹤0.01% | 4151 |
|
|
2024
Q3 | $36.9K | Sell |
1,281
-196
| -13% | -$5.64K | ﹤0.01% | 4298 |
|
|
2024
Q2 | $21.4K | Buy |
1,477
+1,230
| +498% | +$17.8K | ﹤0.01% | 4243 |
|
|
2024
Q1 | $3.97K | Sell |
247
-961
| -80% | -$15.5K | ﹤0.01% | 4561 |
|
|
2023
Q4 | $24K | Buy |
1,208
+376
| +45% | +$7.48K | ﹤0.01% | 4162 |
|
|
2023
Q3 | $13.6K | Sell |
832
-298
| -26% | -$4.86K | ﹤0.01% | 3779 |
|
|
2023
Q2 | $23.9K | Buy |
1,130
+407
| +56% | +$8.6K | ﹤0.01% | 4238 |
|
|
2023
Q1 | $14.5K | Sell |
723
-57
| -7% | -$1.15K | ﹤0.01% | 3959 |
|
|
2022
Q4 | $20.4K | Buy |
+780
| New | +$20.4K | ﹤0.01% | 3886 |
|
|
2022
Q2 | – | Sell |
-369,008
| Closed | -$1.84M | – | 5747 |
|
|
2022
Q1 | $1.84M | Buy |
+369,008
| New | +$1.84M | ﹤0.01% | 1847 |
|
|
2021
Q4 | – | Sell |
-495,446
| Closed | -$2.72M | – | 5248 |
|
|
2021
Q3 | $2.72M | Buy |
+495,446
| New | +$2.72M | ﹤0.01% | 1697 |
|